Higher level of systemic C-Reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: The three-city study

Journal of the American Geriatrics Society

Volumn 58, Issue 1, 2010, Pages 129-135

  Straczek, Celine ^a,b   Ducimetiere, Pierre ^c   Barberger Gateau, Pascale ^d   Helmer, Catherine ^d   Ritchie, Karen ^d   Jouven, Xavier ^a,b   Carcaillon, Laure ^d   Amouyel, Philippe ^d   Tzourio, Christophe ^d   Empana, Jean Philippe ^a,b  

^a PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d INSERM   (France)

Author keywords

Atherosclerosis; Coronary heart disease; Elderly; Epidemiology; Inflammation

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COMMUNITY SAMPLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGED; C-REACTIVE PROTEIN; CORONARY DISEASE; FEMALE; FRANCE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 73949145312     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02625.x     Document Type: Article

References (30)

1. Libby P, Sukhova G, Lee RT et al. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 1995 25 (Suppl 2) : S9 S12.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999 340 : 115 126.
3. van der Wal AC, Becker AE, van der Loos CM et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994 89 : 36 44.
4. Luc G, Bard JM, Juhan-Vague I et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: The PRIME Study. Arterioscler Thromb Vasc Biol 2003 23 : 1255 1261.
5. Pai JK, Pischon T, Ma J et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004 351 : 2599 2610. (Pubitemid 39628581)
6. Ridker PM, Rifai N, Rose L et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 347 : 1557 1565.
7. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004 350 : 1387 1397.
8. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 107 : 499 511.
9. Cesari M, Penninx BW, Newman AB et al. Inflammatory markers and onset of cardiovascular events: Results from the Health ABC study. Circulation 2003 108 : 2317 2322. (Pubitemid 37413536)
10. Tracy RP, Lemaitre RN, Psaty BM et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997 17 : 1121 1127.
11. van der Meer IM, de Maat MP, Kiliaan AJ et al. The value of C-reactive protein in cardiovascular risk prediction: The Rotterdam Study. Arch Intern Med 2003 163 : 1323 1328.
12. Tzoulaki I, Murray GD, Lee AJ et al. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation 2007 115 : 2119 2127.
13. Pradhan AD, Manson JE, Rossouw JE et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative Observational Study. JAMA 2002 288 : 980 987.
14. Cushman M, Arnold AM, Psaty BM et al. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: The Cardiovascular Health Study. Circulation 2005 112 : 25 31.
15. Manolio TA, Pearson TA, Wenger NK et al. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol 1992 2 : 161 176.
16. Kronmal RA, Cain KC, Ye Z et al. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993 153 : 1065 1073.
17. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005 66 : 265 275.
18. The 3C Study Group. Vascular factors and risk of dementia: Design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003 22 : 316 325.
19. Empana JP, Zureik M, Gariepy J et al. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: The Three-City Study. Stroke 2007 38 : 893 899.
20. Zureik M, Ducimetiere P, Touboul PJ et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: Llongitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol 2000 20 : 1622 1629.
21. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol 1957 17 : 237 246.
22. Kulathinal S, Karvanen J, Saarela O et al. Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov 2007 4 : 15.
23. Cao JJ, Arnold AM, Manolio TA et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: The Cardiovascular Health Study. Circulation 2007 116 : 32 38.
24. Lloyd-Jones DM, Liu K, Tian L et al. Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006 145 : 70 72.
25. Zethelius B, Berglund L, Sundstrom J et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008 358 : 2107 2116.
26. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008 359 : 2195 2207. Epub 2008 Nov 9.
27. CRP CHD Genetics Collaboration. Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: Judging causality by Mendelian randomisation. Eur J Epidemiol 2008 23 : 531 540.
28. Lange LA, Carlson CS, Hindorff LA et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006 296 : 2703 2711.
29. Kivimaki M, Lawlor DA, Smith GD et al. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS ONE 2008 3 : e3013.
30. Zacho J, Tybjaerg-Hansen A, Jensen JS et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008 359 : 1897 1908.